2015
DOI: 10.1038/nrm3949
|View full text |Cite
|
Sign up to set email alerts
|

The selection and function of cell type-specific enhancers

Abstract: Preface The human body contains several hundred cell types, all with the same genome. In metazoans, much of the regulatory code that drives cell type-specific gene expression resides in distal elements called enhancers. Enhancers are activated by proteins called transcription factors that bind specific DNA motifs and recruit co-regulators to ultimately activate transcription. While the human genome contains millions of potential enhancers, only a small subset of them is active in a given cell type. Densely spa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

45
830
0
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 881 publications
(900 citation statements)
references
References 131 publications
45
830
0
2
Order By: Relevance
“…Unlike promoters, enhancers often regulate expression of their target genes independent of their relative location, distance or even the gene orientation (Ong and Corces, 2011). Furthermore, enhancers are often tissue-or cell type-specific (Heinz et al, 2015;Pennacchio et al, 2013). Due to the relative location and tissue specificity, it is challenging to identify enhancers.binding sites often represent regulatory elements (Spitz and Furlong, 2012), and chromatin immunoprecipitation followed by sequencing (ChIP-seq) or ChIP-chip can be used to identify the binding sites of various TFs or other regulatory factors; (ii) A few enhancer-specific factors have been used to identify enhancers.…”
Section: Introductionmentioning
confidence: 99%
“…Unlike promoters, enhancers often regulate expression of their target genes independent of their relative location, distance or even the gene orientation (Ong and Corces, 2011). Furthermore, enhancers are often tissue-or cell type-specific (Heinz et al, 2015;Pennacchio et al, 2013). Due to the relative location and tissue specificity, it is challenging to identify enhancers.binding sites often represent regulatory elements (Spitz and Furlong, 2012), and chromatin immunoprecipitation followed by sequencing (ChIP-seq) or ChIP-chip can be used to identify the binding sites of various TFs or other regulatory factors; (ii) A few enhancer-specific factors have been used to identify enhancers.…”
Section: Introductionmentioning
confidence: 99%
“…Compared with typical enhancers, superenhancers are more cell-lineage-specific and control cell identity (4). Enhancer activation is orchestrated through a regulatory network involving lineage-determining TFs and chromatinmodifying complexes (2). However, how chromatin-modifying complexes regulate enhancer activation and cell fate transition is poorly understood.…”
mentioning
confidence: 99%
“…enhancer | MLL4/KMT2D | H3K4 methyltransferase | cell fate transition | p300 I n mammalian cells, enhancers coordinate with promoters to precisely control cell-type-specific gene transcription, which determines the cell identity (1,2). Comprehensive genome-wide studies have provided insights into the chromatin signatures of enhancers.…”
mentioning
confidence: 99%
“…Delineating the global ccRCC cis-regulatory landscape may also identify master regulators involved in tissue-specific disease processes. Compared with promoters that are largely cell-type invariant, distal enhancers integrate multiple lineage-and context-dependent signals, catering to the specialized needs of diverse cell types and diseases (32,33). In cancer, such master regulators are frequently located near "superenhancers" or "stretch-enhancers" marked by long stretches of H3K27ac signals (34,35).…”
mentioning
confidence: 99%